Patent Yard Sign in
Expired European patentEurope

The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence

EP 0750909 B1 · Applicant: NANNING MAPLE LEAF PHARMACEUTICAL CO., LTD.

EPO PDF

Overview

The published document from the EPO: abstract, claims, description and drawings. Open it full size

Read the whole patent

Listed from its EPO record in Patent Yard's archive of European patents past their term. Its claims, description and drawings are in the EPO PDF and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed March 11, 1995 and granted December 11, 2002. A European patent lasts at most 20 years from filing, so its term ended March 11, 2015.
  • A supplementary protection certificate, which can extend a medicine or crop-protection patent, adds at most five and a half years, so even that would have ended by September 11, 2020.
  • We check European rights only. A US or other national patent in its family could still be in force: check its family on Espacenet or Google Patents.
FiledMarch 11, 1995
PublishedJanuary 2, 1997
GrantedDecember 11, 2002
Term endedMarch 11, 2015
Application numberEP 95911187
Classification (CPC)A61P15/00 +2 more

Timeline

Timeline From EPO dates

1996199820002002200420062008201020122014Application filedMarch 11, 1995PublishedJan 2, 1997Patent grantedDec 11, 2002Term endedMarch 11, 2015

Sources & verification